Trump Exec Order to Help Restore Wealth for American Citizens?

Thanks to President Trump's Executive Order 14179, a brief "AI Wealth Window" is opening now. Genius investor James Altucher has released 3 AI wealth-building strategies to take advantage of Trump's genius Executive Order 14179. James believes you could see $10,000 grow to $1 MILLION or more over the next few years.

Jasper Therapeutics Shares Fall On Briquilimab Drug Lot Problem

Vandana Singh
July 07, 2025

Jasper Therapeutics, Inc. (NASDAQ:JSPR) stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.

What Happened?

The company reported updated data from the BEACON Phase 1b/2a study of subcutaneous briquilimab in adult chronic spontaneous urticaria (CSU) participants and provided an update on the program. It reported preliminary data in January.

The primary endpoints are briquilimab’s safety and tolerability, and the secondary endpoints are focused on clinical activity and PK/PD.

Also Read: InflaRx Ends Lead Asset Development After Failed Study For Rare And Painful Skin Disease

Primary measurements used to assess clinical activity were the sum of the Hives Severity Score and the daily Itch Severity Score (ISS), as measured via the Urticaria Activity Score over 7 days (UAS7) on a 0 to 42-point scale.

Briquilimab administration resulted in disease control in the 240mg and 360mg single-dose cohorts.

Eight of nine (89%) participants enrolled across both cohorts achieved a complete response, and seven of nine (78%) achieved a clinical response by week 2.

Reductions in UAS7 scores were reported with a mean change from baseline at 4 weeks of 28.3 points in the 240mg single-dose cohort and 22.9 points in the 360mg single-dose cohort.

In addition, BEACON participants who rolled over into the open-label extension study dosing at 180mg Q8W demonstrated clinical efficacy with 8 of 11 (73%) participants achieving a complete response at 12 weeks.

Results from the 240mg Q8W and the 240mg followed by 180mg Q8W dose cohorts appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed with drug from the lot in question.

The company is investigating the drug product lot in question. It expects to have the investigation results in the coming weeks.

Key observations noted in those 10 patients were lower than expected drops in mean tryptase levels and no discernable impact on UAS7 scores. The 2 participants enrolled in the cohorts that have been confirmed as being dosed with drug product from a different lot both achieved complete response.

The company also plans to enroll an additional 10-12 patients across the 240mg Q8W and the 240mg followed by 180mg Q8W cohorts to ensure a robust data set to inform the Phase 2b CSU study.

Data from the additional BEACON patients is expected in the fourth quarter of 2025, and commencement of the Phase 2b study is now expected in mid-2026.

The company has also determined that the drug product lot in question was used to treat participants enrolled in the ETESIAN trial evaluating briquilimab in asthma.

Why It Matters?

To focus resources on advancing briquilimab in CSU, the company is halting the asthma study and pausing development.

In addition, the company is halting development in SCID and will implement several other cost-cutting measures, including a potential restructuring, to extend the runway and reduce expenses.

Briquilimab treatment also resulted in deep and durable disease control in the open-label extension study evaluating briquilimab at 180mg Q8W, with 8 of 11 participants (73%) achieving a complete response at the week 12 assessment.

Substantial reductions in tryptase were observed as early as the week 1 assessment and were correlated with the onset of clinical responses. Tryptase levels below the lower limit of quantification were reported for 8 of 10 (80%) participants across the 240mg and 360mg single-dose cohorts.

Briquilimab was tolerated well in the BEACON study and the open-label extension, with no dose-limiting toxicities observed.

Price Action: JSPR stock is down 54.5% at $3.08 at the last check on Monday.

Read Next:

Photo by PeopleImages.com – Yuri A via Shutterstock

Continue Reading...

Popular

Social Security whistleblower who claims DOGE mishandled Americans' sensitive data resigns from post

WASHINGTON (AP) — A Social Security official who has filed a whistleblower complaint alleging the Department of Government Efficiency officials Americans' sensitive information says he's resigning his post because of actions taken against him since making his complaint.

IRS Reportedly Confirms $1,390 Stimulus Checks For Eligible Americans, Rumors of $2,000 August Payout Debunked — Plans Late Summer Rollout (UPDATED)

Millions of Americans may be eligible for a $1,390 stimulus check by the U.S. Department of the Treasury and the Internal Revenue Service, as part of a plan aiming to provide financial relief to low and middle-income households.

How 433 Investors Unlocked 400X Return Potential - Ad

VCs back startups for outsized gains. Regular investors wait. But rule changes fixed that. Take Revolut. In 2016, 433 people averaged a $2,370 stake. Today? It's worth $1M+, up 89,900%. No wonder 10K+ people and the VCs behind Uber and eBay took the chance on Pacaso's $1.3T market disruption.

Congresswoman Files Hundreds Of Stock Trades Late, Including Palantir Stock Up Over 600%

A Congresswoman violated the Stock Act with a disclosure showing hundreds of stock transaction made dating back to March 2024.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

Billionaire Investor Buys Google And This Gold Miner Stock

John Paulson's hedge fund discloses the purchase of 9,000 shares of Alphabet.

Kevin O'Leary Recalls How Cutting Off His Son's Trust Fund Drove Him To Harvard: 'The Dead Bird Under The Nest Never Learns To Fly'

Kevin O'Leary revealed that cutting off his son's trust fund after high school and insisting on self-reliance motivated him to earn a spot at Harvard, emphasizing that entitlement ruins ambition.

Buffett's Favorite Chart Just Hit 209% - Here's What That Means For Gold - Ad

Buffett's favorite market signal just hit its highest level in history-stocks are more overvalued than 1929. He's sitting on $325B in cash... and may be about to buy one overlooked gold miner. I've identified it-plus 4 others with up to 100X potential.

Jim Cramer Refuses To Chase Rally—Says 'We Sure Aren't Buying' Unless It's Discounted

Jim Cramer is sitting out the current market rally, citing excessive intervention, overbought conditions as key reasons to remain cautious.

October 16 Changes the Microchip Game - and Investing - Ad

George Gilder-dubbed "America's #1 Futurist"-says while everyone's chasing AI, the real opportunity is in a 4-nanometer tech millions of times more complex. It's not another chip - it replaces them. Now built in Arizona, Gilder says 3 companies tied to this "super-convergence" could soar.

Sunrun (RUN) Stock Soars As Wells Fargo Nearly Doubles Price Target

Sunrun shares are surging Friday afternoon. Wells Fargo analyst Michael Blum reiterated an Overweight rating on Sunrun.

Here's How A $13 GameStop Purchase Turned Into a $115,000 Bitcoin Jackpot

A GameStop customer has struck gold, discovering a Bitcoin (CRYPTO: BTC) worth approximately $115,000 in a $13 pack of Cardsmith’s Currency trading cards.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Dell Struggles To Protect Margins As Supply Chain Costs Mount

Dell's revenue surged on strong AI server sales, but margin pressure from supply chain costs and aggressive pricing weighed on guidance.

Rural Colorado mourns 6 who died from suspected gas exposure at dairy farm

Six workers who died in what authorities suspect was include a 50-year-old father and two sons, an incident that left rural Colorado communities in mourning.

Gold Is Soaring. Here's How To Get Paid From It - Ad

Gold just broke through $3,300. And while the headlines shout about price targets, something even more powerful is happening behind the scenes. Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. Just a simple fund delivering monthly payouts.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

China Doesn't Need Nvidia? Futurum CEO Calls That 'Next-Level Nonsense' — Dan Ives Reacts With A Fiery Response

Futurum CEO Daniel Newman and analyst Dan Ives dismissed claims that China no longer needs Nvidia, pointing to the company's new B30A chip, Trump's export deal, and setbacks with Chinese rivals that underscore Nvidia's continued dominance in the market.

Intel Deal Splits Experts, Beijing Pressures Alibaba And ByteDance On Nvidia, Zuckerberg Reshuffles AI Again —Tech This Week

The past week has been a rollercoaster ride in the tech world. From President Donald Trump's controversial stake in Intel Corporation to Beijing's backlash against Nvidia Corporation and Mark Zuckerberg's AI restructuring at Meta Platforms, the tech industry has been buzzing with activity. Let's dive into the details.

Elon's New Device Could Launch Biggest IPO of the Decade - Ad

Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.

Stock Of The Day: Will Opendoor Collapse Again?

Opendoor Technologies (OPEN) has reached an important resistance level. There is a good chance that they reverse.

IBM-AMD Alliance Targets Drug Discovery, Climate Modeling With Quantum Supercomputers

IBM and AMD are collaborating to advance quantum computing by integrating IBM's expertise with AMD's technology, aiming for commercially viable applications

Will Your Savings Survive the August 31st Debt Ceiling Crisis? - Ad

On Aug 31, the U.S. runs out of "extraordinary measures" to avoid default. Insiders are moving into crisis-proof assets-while everyday Americans risk losing big. The FREE Mar-A-Lago Accord reveals where they're hiding wealth, how the Fed's response could crush the dollar, and 3 urgent moves to make now.

Stock Market Today: Nvidia Drags Down Nasdaq Futures—Dollar General, Dell, Best Buy In Focus

U.S. stock futures were swinging on Thursday following Wednesday's advances. Futures of major benchmark indices were largely mixed.

This Chinese $30K Tesla Model 3 Rival Secured 10,000 Orders In Seven Minutes

Xpeng's P7 sedan launched in China with over 10,000 orders in 7 mins. Rival Tesla also released new models for Chinese market.

Trump Exec Order to Help Restore Wealth for American Citizens? - Ad

Thanks to President Trump's Executive Order 14179, a brief "AI Wealth Window" is opening now. Genius investor James Altucher has released 3 AI wealth-building strategies to take advantage of Trump's genius Executive Order 14179. James believes you could see $10,000 grow to $1 MILLION or more over the next few years.

Trump's Moves Push Intel To Strongest Week In 25 Years

Intel stock heads for its best week since January 2000 driven by vocal support from President Donald Trump. 

How 433 Investors Unlocked 400X Return Potential - Ad

VCs back startups for outsized gains. Regular investors wait. But rule changes fixed that. Take Revolut. In 2016, 433 people averaged a $2,370 stake. Today? It's worth $1M+, up 89,900%. No wonder 10K+ people and the VCs behind Uber and eBay took the chance on Pacaso's $1.3T market disruption.

The US plans to build a $750M fly factory in Texas to stop a flesh-eating cattle parasite

The U.S. plans to build a $750 million factory in southern Texas to breed billions of sterile flies, ramping up its efforts to keep flesh-eating maggots in Mexico from crossing the border and damaging the American cattle industry.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

Asian shares are mixed in quiet trading as traders await cues from the Fed

BANGKOK (AP) — Shares were mixed in Asia on Tuesday after Wall Street held near its records, with traders awaiting fresh cues about interest rates from the U.S. Federal Reserve.

YouTube TV subscribers may lose access to Fox content, including sports, due to contract dispute

NEW YORK (AP) — Fox channels could soon be pulled from YouTube TV if the two sides don't ink a new content use deal Wednesday, potentially leaving subscribers of the Google-owned streamer without and other content.

Buffett's Favorite Chart Just Hit 209% - Here's What That Means For Gold - Ad

Buffett's favorite market signal just hit its highest level in history-stocks are more overvalued than 1929. He's sitting on $325B in cash... and may be about to buy one overlooked gold miner. I've identified it-plus 4 others with up to 100X potential.

Palantir CEO Alex Karp Dumps $63 Million In Stock As PLTR Surges 111% This Year

Palantir CEO Alex Karp sold $62.7 million in stock amid rising valuation concerns and insider selling pressure, even as the stock remains up 397% year-over-year.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright priceactionea.net
Privacy Policy | Terms of Service